Skip to main content
. 2017 Apr 5;105(5):1166–1175. doi: 10.3945/ajcn.116.150359

TABLE 2.

Association between cumulative averaged dairy intake and breast composition at Tanner breast stage 4 in 290 girls in the Growth and Obesity Cohort Study (2006–2016)1

Fibroglandular volume,2 %
Fibroglandular volume,2 cm3
Category of intake Girls, n Model 1 Model 2 Model 1 Model 2
Total dairy, g/d
 Q1 (≤149) 71 Reference Reference Reference Reference
 Q2 (150–256) 74 0.2 (−5.3, 5.9) 0.9 (−2.8, 4.6) −1.1 (−11.4, 9.1) −1.0 (−11.1, 9.1)
 Q3 (257–374) 73 1.6 (−3.7, 7.0) −0.5 (−4.2, 3.1) −5.3 (−15.5, 4.8) −5.0 (−15.0, 5.0)
 Q4 (≥375) 72 4.7 (−0.7, 10.1) 1.7 (−2.0, 5.4) 4.6 (−5.7, 14.8) 6.0 (−4.1, 16.1)
P-trend 0.06 0.48 0.44 0.30
High-fat dairy, g/d
 Q1 (≤64) 72 Reference Reference Reference Reference
 Q2 (65–174) 73 −5.0 (−10.5, 0.4) 0.3 (−3.5, 4.1) −1.6 (−12.0, 8.9) −4.9 (−15.4, 5.6)
 Q3 (175–261) 73 1.2 (−4.1, 6.6) 2.7 (−1.0, 6.5) −1.3 (−11.6, 8.9) −2.7 (−12.8, 7.4)
 Q4 (≥262) 72 1.9 (−3.5, 7.2) 1.6 (−2.1, 5.3) 5.3 (−4.9, 15.6) 4.8 (−5.3, 14.9)
P-trend 0.19 0.28 0.27 0.25
Low-fat dairy, g/d
 C1 (0) 95 Reference Reference Reference Reference
 C2 (1–125) 110 1.9 (−2.7, 6.5) −1.7 (−4.8, 1.5) −5.6 (−14.3, 3.1) −4.8 (−13.4, 3.8)
 C3 (126–249) 61 −0.7 (−6.1, 4.6) −2.3 (−6.0, 1.4) −9.9 (−20.0, 0.3) −9.0 (−19.1, 1.1)
 C4 (≥250) 24 5.0 (−2.4, 12.4) 1.9 (−7.0, 3.2) −9.1 (−23.1, 4.9) −6.4 (−20.5, 7.6)
P-trend 0.65 0.28 0.06 0.12
Total milk, g/d
 C1 (0) 80 Reference Reference Reference Reference
 C2 (1–125) 91 2.1 (−3.0, 7.3) 0.6 (−2.9, 4.1) 0.2 (−9.5, 9.9) 0.3 (−9.3, 9.9)
 C3 (126–249) 63 2.7 (−2.8, 8.1) −0.9 (−4.7, 2.9) −0.7 (−11.1, 9.7) −0.0 (−10.4, 10.3)
 C4 (≥250) 56 0.8 (−4.9, 6.4) −1.5 (−5.3, 2.4) 4.6 (−6.1, 15.3) 5.0 (−5.6, 15.6)
P-trend 0.71 0.30 0.53 0.45
High-fat milk, g/d
 C1 (0) 125 Reference Reference Reference Reference
 C2 (1–125) 79 3.0 (−1.8, 7.8) 1.6 (−1.7, 4.9) −0.4 (−9.5, 8.7) 0.5 (−8.6, 9.6)
 C3 (>125) 86 2.0 (−2.6, 6.6) −0.1 (−3.2, 3.0) 2.9 (−5.8, 11.6) 3.6 (−5.0, 12.2)
P-trend 0.36 0.98 0.53 0.42
Low-fat milk, g/d
 C1 (0) 206 Reference Reference Reference Reference
 C2 (1–125) 53 −3.3 (−8.4, 1.8) −3.9 (−7.4, −0.5) −5.8 (−15.4, 3.9) −6.5 (−16.1, 3.0)
 C3 (>125) 31 −2.1 (−8.3, 4.2) −2.0 (−6.2, 2.2) 1.3 (−10.5, 13.1) 0.9 (−10.7, 12.6)
P-trend 0.29 0.08 0.77 0.67
Yogurt, g/d
 C1 (0) 123 Reference Reference Reference Reference
 C2 (1–125) 110 1.9 (−2.5, 6.3) −1.2 (−4.2, 1.9) −6.9 (−15.1, 1.4) −6.7 (−15.1, 1.6)
 C3 (>125) 57 2.9 (−2.3, 8.1) −0.3 (−3.9, 3.3) −12.1 (−21.9, −2.3) −10.2 (−20.2, −0.3)
P-trend 0.25 0.77 0.01 0.03
Mixed-dairy beverage, g/d
 C1 (0) 182 Reference Reference Reference Reference
 C2 (1–125) 63 −1.8 (−6.7, 3.1) 2.9 (−0.4, 6.2) 0.3 (−9.0, 9.7) −1.3 (−10.6, 8.0)
 C3 (>125) 45 3.9 (−1.5, 9.3) 4.5 (0.9, 8.1) 3.0 (−7.2, 13.3) 2.1 (−8.0, 12.1)
P-trend 0.33 0.007 0.60 0.80
1

C, category; Q, quartile.

2

All values are βs (95% CIs). βs were estimated from a linear regression model that was adjusted for total calorie intake, age at Tanner breast stage 4, sugar-sweetened beverage intake, television watching after school, and highest maternal educational level. Model 2 was adjusted as for model 1 and for BMI-for-age z score and height. For all specific dairy types, βs represent absolute differences in outcomes (percentage of fibroglandular volume and fibroglandular volume) in the second, third, and fourth categories of intake compared with in the first category of intake (the reference category). Tests for trend across categories were conducted with the use of a variable with the median value in each category as a continuous variable.